Skip to content

SYNERGY™ XD H7493941828270Recalls & reported problems

Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant

All models of SYNERGY XD (65)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729980919), received between Sep 20, 2021 and Feb 4, 2026 — classified as 1 injury, 3 malfunctions.

The most frequently reported specific device problem is “Material Deformation” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Deformation2
  • Break1
  • Difficult to Remove1
  • Failure to Advance1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 4, 2026Break

    IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERY DISEASE AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED VESSEL. A 2.75 X 28MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED AND DEPLOYED WITHOUT ANY ISSUES. HOWEVER, WHEN PULLING THE STENT BALLOON OUT OF THE PATIENT'S BODY OVER A NON-BOSTON SCIENTIFIC (BSC) GUIDEWIRE, IT WAS NOTED THAT THE MONORAIL PORTION SEPARATED FROM THE STENT SHAFT AT THE POINT WHERE THE MONORAIL PORTION WAS FUSED. THE MONORAIL PORTION REMAINED ON THE WIRE INSIDE THE GUIDE, AND EVERYTHING WAS PULLED OUT IN ONE PIECE; AND NOTHING WAS LEFT INSIDE THE PATIENT'S BODY. IN ADDITION, THERE WERE NO NOTICEABLE DAMAGE OBSERVED ON THE SHAFT OF THE STENT DELIVERY DEVICE PRIOR TO DEPLOYMENT. THERE WERE NO PATIENT COMPLICATIONS AND THE PATIENT FULLY RECOVERED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24259078 ↗
  • MalfunctionJan 21, 2022Failure to Advance; Material Deformation; Failure to Advance; Material Deformation

    IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE >70% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED IN OBTUSE MARGINAL ARTERY. FOLLOWING PRE-DILATION, A 2.75 X 28MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, THE DEVICE WOULD NOT CROSS THE LESION. THE PHYSICIAN PULLED THE STENT BACK OUT AND IT WAS NOTICED THAT THE STENT WAS DAMAGED AND LOOKED LIKE IT GOT CAUGHT ON SOMETHING AND "UNRAVELED." THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13318334 ↗
  • InjuryOct 7, 2021Difficult to Remove; Difficult to Remove

    IT WAS REPORTED THAT REMOVAL DIFFICULTIES WERE ENCOUNTERED. THE 80% STENOSED TARGET LESION WAS LOCATED IN LEFT ANTERIOR DESCENDING ARTERY. A 2.75 X 28MM SYNERGY XD DRUG-ELUTING STENT WAS DEPLOYED, HOWEVER, THE STENT DELIVERY SYSTEM BECAME STUCK INSIDE OF THE STENT. A SECOND WIRE WAS USED TO SUCCESSFULLY REMOVE THE DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12594541 ↗
  • MalfunctionSep 20, 2021Material Deformation; Material Deformation

    IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN A CALCIFIED CORONARY ARTERY. A 2.75 X 28MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, WHILE TRYING TO CROSS THE LESION, IT WAS NOTED THAT THE STENT WAS DAMAGED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT'S STATUS WAS STABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12502204 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page